VAERS reports by lot

GSK DTaP/Tdap lot 3457Y: VAERS reports

20 VAERS reports list lot 3457Y as a GSK DTaP/Tdap vaccine, received between 2017-01-19 and 2020-02-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
20%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2423%
Injection-site / Local reaction1414%
Neurological1313%
Musculoskeletal1313%
Dermatological (non-injection-site)1010%
Cardiac / Cardiovascular99%
Allergic / Anaphylactic77%
Gastrointestinal77%
Respiratory22%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
New Jersey3
New York3
Washington2
Utah1
Virginia1
Ohio1
Colorado1
Idaho1
Mississippi1
California1
Rhode Island1

Reports by month received

2017-011
2017-032
2017-067
2017-074
2017-082
2017-091
2017-101
2020-022

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.